StockData
Lifecore Biomedical, Inc. logo

Lifecore Biomedical, Inc. (LFCR) income statement

LFCRNasdaqPharmaceutical PreparationsFiscal year ends May 25
Financials through Q4 FY2025, quarter ended May 25, 2025Last filing: 10-Q on Nov 4, 2026Score 4/30
$6.39+0.02 (+0.31%)

Close on Nov 20, 2026Market cap $241.88MP/E –Yield –

See a number that looks wrong?